Text Messaging to Improve Hypertension Medication Adherence in African Americans: BPMED Intervention Development and Study Protocol.

Text Messaging to Improve Hypertension Medication Adherence in African Americans: BPMED Intervention Development and Study Protocol.
复制标题

DOI:
10.2196/resprot.4040
复制
发表时间:
2015-01-02
影响因子:
1.7
通讯作者:
Levy PD
Levy PD
中科院分区:
其他
文献类型:
--
作者:
Buis LR;Artinian NT;Schwiebert L;Yarandi H;Levy PD

文献摘要

参考文献

被引文献

相似文献

高血压(HTN)是美国的一个主要公共卫生问题,近7800万20岁及以上的美国人患有这种疾病。此外,HTN是健康疾病和中风的关键危险因素。非裔美国人不成比例地承担HTN的负担,与年龄匹配的白人相比,患病率更高,疾病严重程度更高,发病更早,HTN相关并发症更多。HTN治疗的药物依从性较差,估计表明只有约一半的高血压患者依从处方药物治疗方案。尽管没有任何一种改善药物依从性的干预措施上级其他干预措施,但短信药物提醒有可能帮助改善患有不受控制的HTN的非裔美国人的药物依从性,因为该人群中移动的的使用率非常高。这项两阶段研究的目的是在随机对照试验(RCT)中开发(I期)和测试(II期)短信系统BPMED,通过增加非裔美国人不受控制的HTN的药物依从性来提高药物管理的质量。在第一阶段,我们从一家初级保健诊所招募了16名目标最终用户,通过参加三个焦点小组之一来协助BPMED的发展。焦点小组试图获得患者对HTN、药物依从性、移动的电话使用和使用短信支持药物依从性的观点。向参与者介绍了潜在的干预设计,并征求了对设计的反馈意见。在第二阶段,我们进行了两个试点随机对照试验,以确定BPMED在初级保健和急诊科设置的可行性,可接受性和初步疗效。这两项试点研究招募了大约60名参与者,他们在常规护理和BPMED干预之间随机分配。虽然数据收集现已完成,但两项试点随机对照试验的数据分析仍在进行中,预计2015年将得出结果。本研究的目的是确定我们的方法在非裔美国人与不受控制的HTN在初级保健和急诊科设置的初步可行性和可接受性。这些研究的结果非常有趣,因为很少有工作记录使用短信药物提醒来改善HTN相关的结果,特别是在服务不足的城市少数民族中。Clinicaltrials.gov NCT 01465217; https://clinicaltrials.gov/ct2/show/NCT01465217(由WebCite存档,网址为http://www.webcitation.org/6V0tto0lZ)。
Hypertension (HTN) is a major public health concern in the United States, with almost 78 million Americans age 20 years and over suffering from the condition. Moreover, HTN is a key risk factor for health disease and stroke. African Americans disproportionately shoulder the burdens of HTN, with greater prevalence, disease severity, earlier onset, and more HTN-related complications than age-matched whites. Medication adherence for the treatment of HTN is poor, with estimates indicating that only about half of hypertensive patients are adherent to prescribed medication regimens. Although no single intervention for improving medication adherence has emerged as superior to others, text message medication reminders have the potential to help improve medication adherence in African Americans with uncontrolled HTN as mobile phone adoption is very high in this population. The purpose of this two-phased study was to develop (Phase I) and test in a randomized controlled trial (RCT) (Phase II) a text message system, BPMED, to improve the quality of medication management through increasing medication adherence in African Americans with uncontrolled HTN. In Phase I, we recruited 16 target end-users from a primary care clinic, to assist in the development of BPMED through participating in one of three focus groups. Focus groups sought to gain patient perspectives on HTN, medication adherence, mobile phone use, and the use of text messaging to support medication adherence. Potential intervention designs were presented to participants, and feedback on the designs was solicited. In Phase II, we conducted two pilot RCTs to determine the feasibility, acceptability, and preliminary efficacy of BPMED in primary care and emergency department settings. Both pilot studies recruited approximately 60 participants, who were randomized equally between usual care and the BPMED intervention. Although data collection is now complete, data analysis from the two pilot RCTs is still ongoing and results are expected in 2015. This study was designed to determine preliminary feasibility and acceptability of our approach among African Americans with uncontrolled HTN in primary care and emergency department settings. Results from these studies are of great interest as little work has been done to document the use of text message medication reminders to improve HTN-related outcomes, particularly within underserved urban minorities. Clinicaltrials.gov NCT01465217; https://clinicaltrials.gov/ct2/show/NCT01465217 (Archived by WebCite at http://www.webcitation.org/6V0tto0lZ).
DOI: 10.1161/01.cir.0000441139.02102.80
发表时间: 2014-01-21
期刊: Circulation
影响因子: 37.8
作者:
Go AS;Mozaffarian D;Roger VL;Benjamin EJ;Berry JD;Blaha MJ;Dai S;Ford ES;Fox CS;Franco S;Fullerton HJ;Gillespie C;Hailpern SM;Heit JA;Howard VJ;Huffman MD;Judd SE;Kissela BM;Kittner SJ;Lackland DT;Lichtman JH;Lisabeth LD;Mackey RH;Magid DJ;Marcus GM;Marelli A;Matchar DB;McGuire DK;Mohler ER 3rd;Moy CS;Mussolino ME;Neumar RW;Nichol G;Pandey DK;Paynter NP;Reeves MJ;Sorlie PD;Stein J;Towfighi A;Turan TN;Virani SS;Wong ND;Woo D;Turner MB;American Heart Association Statistics Committee and Stroke Statistics Subcommittee
通讯作者: American Heart Association Statistics Committee and Stroke Statistics Subcommittee
DOI: 10.1097/aog.0b013e3181eb6b0f
发表时间: 2010-09-01
影响因子: 7.2
作者:
Hou, Melody Y.;Hurwitz, Shelley;Goldberg, Alisa B.
通讯作者: Goldberg, Alisa B.
DOI: 10.1016/j.jaad.2012.02.031
发表时间: 2012-12-01
影响因子: 13.8
作者:
Boker, Andreas;Feetham, H. Jill;Jacobe, Heidi
通讯作者: Jacobe, Heidi
DOI: 10.1001/jamaophthalmol.2014.857
发表时间: 2014-07-01
期刊: JAMA OPHTHALMOLOGY
影响因子: 8.1
作者:
Boland, Michael V.;Chang, Dolly S.;Friedman, David S.
通讯作者: Friedman, David S.
DOI: 10.1016/s0895-4356(03)00053-2
发表时间: 2003-06-01
影响因子: 7.2
作者:
Ogedegbe, G;Mancuso, CA;Charlson, ME
通讯作者: Charlson, ME